nicotine has been researched along with oligonucleotides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Abed, Y; Justiniani, M; Liao, H; Lin, X; Metz, C; Miller, EJ; Ochani, M; Tracey, KJ; Ulloa, L; Wang, H; Yang, L | 1 |
| Benoit, M; Bhattacharya, K; Cartier, J; Davis, HL; Finneman, JI; Gervais, DP; Kim, IJ; McCluskie, MJ; Merson, JR; Stead, DR; Thorn, J; Zhang, N | 1 |
2 other study(ies) available for nicotine and oligonucleotides
| Article | Year |
|---|---|
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cecum; Fluorescent Antibody Technique; HMGB1 Protein; Humans; Inflammation; Lipopolysaccharides; Macrophages; Mice; Neuroimmunomodulation; Nicotine; Oligonucleotides; Receptors, Nicotinic; Sepsis; Signal Transduction | 2004 |
Anti-nicotine vaccines: Comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates.
Topics: Adjuvants, Immunologic; Animals; Antibodies; Bacterial Proteins; Brain; Female; Haptens; Immunoconjugates; Macaca fascicularis; Male; Nicotine; Oligonucleotides; Time Factors; Vaccines; Vaccines, Synthetic | 2015 |